Virus injection plus immunotherapy for advanced breast cancer
Part of Cancer, Skin clinical trials.
This study tests a new approach that combines a modified virus (H101) injected directly into the tumor with immunotherapy drugs that help your immune system fight cancer. It is for people with advanced breast cancer who have already tried standard treatments and could not continue chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your breast cancer has spread to other parts of the body (stage IV).
- You have tried at least one standard treatment for breast cancer and it has stopped working.
- You are not able to get, or have decided to stop, standard chemotherapy.
- You have at least one tumor that can be safely injected with a needle for the study treatment.
- You are willing to provide blood and tumor tissue samples before and after treatment for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special virus injected directly into tumors can help your body fight cancer when combined with an immunotherapy drug. It is for people with advanced colorectal, stomach, or liver cancer that has spread and who have tumors that can be reached for injection.
This study tests a new combination treatment: a modified virus (hV01) injected directly into a tumor, plus a drug that helps your immune system attack cancer cells (PD-1 inhibitor). It is for people with advanced solid tumors that have not responded to standard therapies.
This trial tests a new treatment that combines a cancer-killing virus with an immunotherapy drug (a PD-1 inhibitor) for advanced pancreatic cancer. It aims to see if this combination can help shrink tumors and improve outcomes for patients who have already tried chemotherapy.
This trial tests an experimental cell therapy (HS-IT101) for people with advanced solid tumors that have not responded to standard treatments. It uses immune cells from your own tumor to fight cancer, and researchers want to see if it is safe and effective.
This trial tests combining a special virus injected directly into the tumor with two approved drugs (tislelizumab and lenvatinib) for advanced liver cancer that hasn't been treated before. The goal is to see if this triple approach can shrink tumors and improve outcomes.
This trial tests whether immune cells taken from your own tumor (called tumor-infiltrating lymphocytes) can be grown in a lab and given back to you to fight the cancer. It is for people with advanced breast cancer who have exhausted standard treatment options.
Hear when a new Breast Cancer (Locally Advanced or Metastatic) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.